Showing results (131-140 of 180) with videos related to
Sort By:
Pageof 18
The Journal of Pathology|September 20, 2018
Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumorsKevin M Elias, Petros Tsantoulis, Jean-Christophe Tille, et al.Scientific Reports|January 27, 2023
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinomaSho Sato, Michael Gillette, Pamela R de Santiago, et al.Nature Cancer|June 4, 2021
Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinomaShuai Wu, Takeshi Fukumoto, Jianhuang Lin, et al.Science Translational Medicine|August 17, 2012
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4Yin Ren, Hiu Wing Cheung, Geoffrey von Maltzhan, et al.JCI Insight|January 19, 2017
A patient-derived-xenograft platform to study BRCA-deficient ovarian cancersErin George, Hyoung Kim, Clemens Krepler, et al.Gynecologic Oncology Reports|April 18, 2022
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinomaElizabeth H Stover, Niya Xiong, Andrea P Myers, et al.Molecular Cell|October 21, 2015
PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell GrowthEmily D Montal, Ruby Dewi, Kavita Bhalla, et al.Cell Reports. Medicine|October 8, 2021
<i>CCNE1</i> copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer modelsHaineng Xu, Erin George, Yasuto Kinose, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2012
Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcomeZhigang C Wang, Nicolai Juul Birkbak, Aedín C Culhane, et al.Genes & Development|July 13, 2017
PRKCI promotes immune suppression in ovarian cancerSharmistha Sarkar, Christopher A Bristow, Prasenjit Dey, et al.Pageof 18